Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Comparative evaluation of suture-assisted and sutureless intrascleral posterior chamber intraocular lens fixation

Poster Details

First Author: Z. Wu CHINA

Co Author(s):    S. Luo                    

Abstract Details

Purpose:

Scleral fixated IOL implantation was performed in patients with inadequate capsular support. Intraocular lens fixation was achieved using suturess. Main parameters evaluated were visual outcomes and complications.

Setting:

Department of Dphthalmology,Wuxi No.2 Hospital of Nangjing Medical University,Wuxi 214000,China

Methods:

Scleral fixated IOL implantation was performed in patients with inadequate capsular support. Intraocular lens fixation was achieved using suturess. Main parameters evaluated were visual outcomes and complications.

Results:

Fifty patients were included in the study (n=30 suture, n=30 sutureless). The most common indication for scleral fixated IOL implantation was cataract surgery complicated with posterior capsule rupture (36/60[60%]). At last follow-up (6 months), CDVA was 20/40 or better in 88% and 84% of patients in the suture and sutureless groups, respectively. Postoperative inflammation (50%vs 12%) and glaucoma (40% vs 15%) were seen more frequently in eyes with sutures as compared to eyes with sutureless. Overall, a significantly higher number of complications were encountered in eyes with suture fixation(17/30 [57%]) compared to eyes with sutureless fixation(8/30 [27%]) (P=0.02).

Conclusions:

Although visual outcomes were similar at the end of 6 months in eyes that underwent suture and sutureless scleral fixated IOL implantation, sutureless was associated with fewer complications.

Financial Disclosure:

NONE

Back to Poster listing